Items where Salford Author is "Sotgia, F"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 50.
Article
Sivalingam, VN, Latif, A, Kitson, S, McVey, R, Finegan, KG, Marshall, K, Lisanti, MP, Sotgia, F, Stratford, IJ and Crosbie, EJ  ORCID: https://orcid.org/0000-0003-0284-8630
2019,
'Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin'
, British Journal of Cancer
.
|
|
|
Pellegrino, M, Rizza, P, Donà, A, Nigro, A, Ricci, E, Fiorillo, M, Perrotta, I, Lanzino, M, Giordano, C, Bonofiglio, D ORCID: https://orcid.org/0000-0002-4142-0496, Bruno, R, Sotgia, F, Lisanti, MP, Sisci, D ORCID: https://orcid.org/0000-0001-6577-1541 and Morelli, C ORCID: https://orcid.org/0000-0002-9407-0805
2019,
'FoxO3a as a positive prognostic marker and a therapeutic target in Tamoxifen-resistant breast cancer'
, Cancers, 11 (12)
, e1858.
|
|
|
Frattaruolo, L ORCID: https://orcid.org/0000-0002-7018-8454, Fiorillo, M, Brindisi, M ORCID: https://orcid.org/0000-0002-5022-9642, Curcio, R, Dolce, V, Lacret, R ORCID: https://orcid.org/0000-0003-1135-3891, Truman, AW ORCID: https://orcid.org/0000-0001-5453-7485, Sotgia, F, Lisanti, MP and Cappello, AR
2019,
'Thioalbamide, a thioamidated peptide from amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress'
, Cells, 8 (11)
, e1408.
|
|
| De Francesco, EM, Ozsvari, B, Sotgia, F and Lisanti, MP 2019, 'Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).' , Frontiers in oncology, 9 , p. 615. |
|
| Peiris-Pagès, M, Ozsvari, B, Sotgia, F and Lisanti, MP 2019, 'Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer : mito-stemness and ribo-stemness features' , Aging, 11 (14) , pp. 4801-4835. |
|
| Fiorillo, M, Tóth, F, Sotgia, F and Lisanti, MP 2019, 'Doxycycline, Azithromycin and vitamin C (DAV) : a potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)' , Aging, 11 (8) , pp. 2202-2216. |
|
| Sotgia, F, Fiorillo, M and Lisanti, MP 2019, 'Hallmarks of the cancer cell of origin : comparisons with "energetic" cancer stem cells (e-CSCs)' , Aging, 11 (3) , pp. 1065-1068. |
|
| Fiorillo, M, Sotgia, F and Lisanti, MP 2019, '“Energetic” cancer stem cells (e-CSCs) : a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy' , Frontiers in Oncology, 8 (677) . |
![[img]](/style/images/fileicons/application_zip.png)
|
| Fiorillo, M, Sanchez-Alvarez, R, Sotgia, F and Lisanti, MP 2018, 'The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling : implicating TIGAR in somatic resistance to endocrine therapy' , Aging, 10 (12) , pp. 4000-4023. |
|
| Ozsvari, B, Nuttall, JR, Sotgia, F and Lisanti, MP 2018, 'Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts' , Aging, 10 (11) , pp. 3294-3307. |
|
| Scatena, C, Roncella, M, Di Paolo, A, Aretini, P, Menicagli, M, Fanelli, G, Marini, C, Mazzanti, CM, Ghilli, M, Sotgia, F, Lisanti, MP and Naccarato, AG 2018, 'Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients : a clinical pilot study' , Frontiers in Oncology, 8 (452) . |
|
| Sotgia, F, Ozsvari, B, Fiorillo, M, De Francesco, EM, Bonuccelli, G and Lisanti, MP 2018, 'A mitochondrial based oncology platform for targeting cancer stem cells (CSCs) : MITO-ONC-RX' , Cell Cycle, 17 (17) , pp. 2091-2100. |
|
| Fiorillo, M, Peiris-Pagès, M, Sanchez-Alvarez, R, Bartella, L, Di Donna, L, Dolce, V, Sindona, G, Sotgia, F, Cappello, AR and Lisanti, MP 2018, 'Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism' , Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1859 (9) , pp. 984-996. |
|
| Bonuccelli, G, Sotgia, F and Lisanti, MP 2018, 'Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways' , Aging, 10 (8) , pp. 1867-1883. |
|
| De Francesco, EM, Sotgia, F and Lisanti, MP 2018, 'Cancer stem cells (CSCs) : metabolic strategies for their identification and eradication' , Biochemical Journal, 475 (9) , pp. 1611-1634. |
|
| Ozsvari, B, Sotgia, F and Lisanti, MP 2018, 'Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs)' , Aging, 10 (2) , pp. 229-240. |
|
| Peiris-Pagès, M, Bonuccelli, G, Sotgia, F and Lisanti, MP 2018, 'Mitochondrial fission as a driver of stemness in tumor cells : mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling' , Oncotarget, 9 (17) , pp. 13254-13275. |
|
| Ozsvari, B, Bonuccelli, G, Sanchez-Alvarez, R, Foster, R, Sotgia, F and Lisanti, MP 2017, 'Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration : vitamin B2 (Riboflavin) in cancer therapy' , Aging, 9 (12) , pp. 2610-2628. |
|
| De Francesco, EM, Sotgia, F, Clarke, RB, Lisanti, MP and Maggiolini, M 2017, 'G protein-coupled receptors at the crossroad between physiologic and pathologic angiogenesis : old paradigms and emerging concepts' , International Journal of Molecular Sciences, 18 (12) . |
|
| De Francesco, EM, Sims, AH, Maggiolini, M, Sotgia, F, Lisanti, MP and Clarke, RB 2017, 'GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment' , Breast Cancer Research, 19 (1) , p. 129. |
|
| Ozsvari, B, Sotgia, F and Lisanti, MP 2017, 'A new mutation-independent approach to cancer therapy : inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.' , Aging, 9 (10) , pp. 2098-2116. |
|
| Ozsvari, B, Sotgia, F, Simmons, K, Trowbridge, R, Foster, R and Lisanti, MP 2017, 'Mitoketoscins : novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs).' , Oncotarget, 8 (45) , pp. 78340-78350. |
|
| Sotgia, F and Lisanti, MP 2017, 'Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer : companion diagnostics for cancer therapy' , Oncotarget, 8 (40) , pp. 66925-66939. |
|
| Sotgia, F and Lisanti, MP 2017, 'Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers : companion diagnostics for personalized medicine.' , Oncotarget, 8 (40) , pp. 67117-67128. |
|
| Sotgia, F and Lisanti, MP 2017, 'Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients : use as companion diagnostics' , Oncotarget, 8 (40) , pp. 68095-68107. |
|
| Sotgia, F, Fiorillo, M and Lisanti, MP 2017, 'Mitochondrial markers predict recurrence, metastasis and Tamoxifen-resistance in breast cancer patients : early detection of treatment failure with companion diagnostics' , Oncotarget, 2017 (8) , pp. 68730-68745. |
![[img]](/style/images/fileicons/application_pdf.png)
|
| Ozsvari, B, Fiorillo, M, Bonuccelli, G, Cappello, AR, Frattaruolo, L, Sotgia, F, Trowbridge, R, Foster, R and Lisanti, MP 2017, 'Mitoriboscins : mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast' , Oncotarget, 2017 (8) , pp. 67457-67472. |
|
| De Francesco, EM, Maggiolini, M, Tanowitz, HB, Sotgia, F and Lisanti, MP 2017, 'Targeting hypoxic cancer stem cells (CSCs) with Doxycycline : implications for optimizing anti-angiogenic therapy' , Oncotarget, 2017 (8) , pp. 56126-56142. |
|
| De Francesco, EM, Bonuccelli, G, Maggiolini, M, Sotgia, F and Lisanti, MP 2017, 'Vitamin C and Doxycycline : a synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)' , Oncotarget, 2017 (8) , pp. 67269-67286. |
|
|
Bakker, EY, Guazzelli, A, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Lisanti, MP, Sotgia, F and Mutti, L
2017,
'Current and prospective pharmacotherapies for the treatment of pleural mesothelioma'
, Expert Opinion on Orphan Drugs, 5 (6)
, pp. 455-465.
|
|
| Fiorillo, M, Sotgia, F, Sisci, D, Cappello, AR and Lisanti, MP 2017, 'Mitochondrial “power” drives tamoxifen resistance : NQO1 and GCLC are new therapeutic targets in breast cancer' , Oncotarget, 2017 (8) , pp. 20309-20327. |
|
|
Guazzelli, A, Bakker, EY, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Lisanti, MP, Sotgia, F and Mutti, L
2017,
'Anti-CTLA-4 therapy for malignant mesothelioma'
, Immunotherapy, 9 (3)
, pp. 273-280.
|
|
| Bonuccelli, G, Peires-Pages, M, Ozsvari, B, Martinez- Outschoorn, U, Sotgia, F and Lisanti, MP 2017, 'Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity' , Oncotarget, 8 (6) , pp. 9868-9884. |
|
| Fiorillo, M, Lamb, R, Tanowitz, H, Cappello, A, Martinez‐Outschoorn, U, Sotgia, Federica and Lisanti, MP 2016, 'Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)' , Aging, 8 (8) , pp. 1593-1607. |
|
|
Fiorillo, M, Lamb, R, Tanowitz, H, Mutti, L, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Cappello, A, Martinez-Outschoorn, U, Sotgia, Federica and Lisanti, MP
2016,
'Repurposing atovaquone : targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells'
, Oncotarget, 7 (23)
, pp. 34084-34099.
|
|
| Peiris-Pagès, M, Martinez-Outschoorn, U, Pestell, R, Sotgia, F and Lisanti, MP 2016, 'Cancer stem cell metabolism' , Breast Cancer Research, 18 (55) . |
|
| Martinez-Outschoorn, U, Peiris-Pagés, M, Pestell, R, Sotgia, Federica and Lisanti, M 2016, 'Cancer metabolism : a therapeutic perspective' , Nature Reviews Clinical Oncology, 14 , pp. 11-31. |
|
| Peiris-Pagès, M, Smith, D, Győrffy, B, Sotgia, Federica and Lisanti, MP 2015, 'Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts' , Aging, 7 (10) , pp. 816-838. |
|
| Farnie, G, Sotgia, Federica and Lisanti, MP 2015, 'High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant' , Oncotarget, 6 (31) , pp. 30472-30486. |
|
| Lamb, R, Bonuccelli, G, Ozsvári, B, Peiris-Pagès, M, Fiorillo, M, Smith DL, DL, Bevilacqua, G, Mazzanti, CM, McDonnell, LA, Naccarato, AG, Chiu, M, Wynne, L, Martinez-Outschoorn, UE, Sotgia, Federica and Lisanti, MP 2015, 'Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells : understanding WNT/FGF-driven anabolic signaling' , Oncotarget, 6 (31) , pp. 30453-30471. |
|
| Lamb, R, Ozsvari, B, Bonuccelli, G, Smith, D, Pestell, R, Martinez-Outschoorn, U, Clarke, R, Sotgia, Federica and Lisanti, MP 2015, 'Dissecting tumor metabolic heterogeneity : Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells' , Oncotarget, 6 (26) , pp. 21892-21905. |
|
| Peiris-Pagès, M, Sotgia, Federica and Lisanti, MP 2015, 'Doxycycline and therapeutic targeting of the DNA damage response in cancer cells : old drug, new purpose' , Oncoscience, 2 (8) , pp. 696-699. |
|
| Casaburi, I, Avena, P, De Luca, A, Chimento, A, Sirianni, R, Malivindi, R, Rago, V, Fiorillo, M, Domanico, F, Campana, C, Cappello, A, Sotgia, Federica, Lisanti, MP and Pezzi, V 2015, 'Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC)' , Oncotarget, 6 (28) , pp. 25135-25148. |
|
| De Luca, A, Fiorillo, M, Peiris-Pagès, M, Ozsvari, B, Smith, D, Sanchez-Alvarez, R, Martinez-Outschoorn, U, Cappello, A, Pezzi, V, Lisanti, MP and Sotgia, Federica 2015, 'Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells' , Oncotarget, 6 (17) , pp. 14777-14795. |
|
| Martinez-Outschoorn, UE, Sotgia, Federica and Lisanti, MP 2015, 'Caveolae and signalling in cancer' , Nature Reviews Cancer, 15 (4) , pp. 225-37. |
|
| Lamb, R, Ozsvari, B, Lisanti, CL, Tanowitz, HB, Howell, A, Martinez-Outschoorn, UE, Sotgia, Federica and Lisanti, MP 2015, 'Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types : treating cancer like an infectious disease' , Oncotarget, 6 (7) , pp. 4569-84. |
|
| Martinez-Outschoorn, UE, Sotgia, F and Lisanti, MP 2014, 'Metabolic asymmetry in cancer : a “balancing act” that promotes tumor growth' , Cancer Cell, 26 (1) , pp. 5-7. |
|
| Mercier, I, Gonzales, DM, Quann, K, Pestell, TG, Molchansky, A, Sotgia, Federica, Hulit, J, Gandara, R, Wang, C, Pestell, RG, Lisanti, MP and Jasmin, J 2014, 'CAPER, a novel regulator of human breast cancer progression' , Cell Cycle, 13 (8) , pp. 1256-1264. |
|
| Martinez-Outschoorn, UE, Lisanti, MP and Sotgia, F 2014, 'Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth' , Seminars in Cancer Biology, 25 , pp. 47-60. |
|
| Lisanti, MP, Reeves, K, Peiris-Pagès, M, Chadwick, AL, Sanchez-Alvarez, R, Howell, A, Martinez-Outschoorn, UE and Sotgia, F 2014, 'JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: Connecting fibrosis, inflammation, and stemness for cancer prevention' , Cell Cycle, 13 (4) , pp. 580-599. |
|